DCM
IDXX icon

DGS Capital Management’s Idexx Laboratories IDXX Stock Holding History

DGS Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.11M Sell
3,750
-442
-11% -$283K 0.35% 51
2025
Q4 		$2.84M Buy
4,192
+447
+12% +$304K 0.49% 32
2025
Q3 		$2.39M Buy
3,745
+2,541
+211% +$1.54M 0.44% 39
2025
Q2 		$646K Buy
1,204
+348
+41% +$166K 0.13% 150
2025
Q1 		$359K Buy
856
+91
+12% +$39.5K 0.09% 202
2024
Q4 		$316K Sell
765
-380
-33% -$167K 0.08% 213
2024
Q3 		$578K Sell
1,145
-116
-9% -$56.4K 0.16% 136
2024
Q2 		$614K Sell
1,261
-26
-2% -$13.1K 0.17% 115
2024
Q1 		$695K Buy
1,287
+223
+21% +$122K 0.2% 96
2023
Q4 		$591K Buy
1,064
+116
+12% +$54.5K 0.23% 86
2023
Q3 		$415K Buy
948
+35
+4% +$17.5K 0.2% 116
2023
Q2 		$459K Buy
913
+3
+0.3% +$1.44K 0.23% 100
2023
Q1 		$455K Buy
910
+45
+5% +$21.5K 0.25% 87
2022
Q4 		$353K Buy
865
+142
+20% +$55.1K 0.23% 108
2022
Q3 		$236K Buy
723
+6
+0.8% +$2.2K 0.16% 153
2022
Q2 		$251K Buy
717
+8
+1% +$3.26K 0.2% 131
2022
Q1 		$388K Buy
709
+127
+22% +$66.8K 0.24% 86
2021
Q4 		$383K Buy
+582
New +$365K 0.24% 75

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DGS Capital Management's IDXX Position: Q1 2026 in Review

DGS Capital Management reduced its Idexx Laboratories (IDXX) stake by 11% in Q1 2026, selling an estimated $283K and leaving 3,750 shares worth $2.11M. The position accounts for 0.35% of the portfolio, ranked #51.

DGS Capital Management first reported a position in IDXX in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.84M in Q4 2025. 1,316 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • DGS Capital Management held 3,750 shares of Idexx Laboratories worth $2.11M as of Q1 2026.
  • DGS Capital Management sold 442 Idexx Laboratories shares in Q1 2026, an estimated $283K.
  • Idexx Laboratories made up 0.35% of DGS Capital Management's portfolio in Q1 2026, its #51 holding.
  • DGS Capital Management first reported a position in Idexx Laboratories in Q4 2021 and has held it in 18 quarters since.
  • DGS Capital Management's Idexx Laboratories position peaked at $2.84M in Q4 2025.
  • 1,316 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on DGS Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.